Isabella Hornick

BOSTON — During COVID-19 hospitalization, patients faced lower odds for mortality and respiratory failure with vs. without documented cannabis use, according to data presented at the CHEST Annual Meeting

BOSTON — Receipt of ventilation vs. extracorporeal membrane oxygenation in adults with obesity and acute respiratory distress syndrome changed the

BOSTON — Having a COPD exacerbation hospitalization in combination with COVID-19 vs. no COVID-19 significantly raised the odds for mortality and invasive ventilation, according to a poster presented at the CHEST Annual Meeting

BOSTON — Having vs. not having past cystic fibrosis transmembrane conductance regulator modulator exposure did not change positive outcomes seen

BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the CHEST Annual Meeting

BOSTON — Among patients with interstitial lung disease, the risk for mortality rose if they lived less than 200 m from a major highway, according to data presented at the CHEST Annual Meeting

BOSTON — In a sample of 114 adults with bronchiectasis, 46.5% received a score that indicated impaired swallow function, according to a presentation at the CHEST Annual Meeting

Key takeaways: Researchers found significantly reduced odds for hypertension and diabetes among those with bronchiectasis vs. COPD.

BOSTON — Patients with COPD faced a decreased risk of severe cardiopulmonary events if treated with single inhaler vs. multiple inhaler triple therapy, according to data presented at the CHEST Annual Meeting

BOSTON — Adults who experienced BMI or weight gains between age 2 years and 5 years, as well as after age 11 years, faced increased odds for high